Immune related adverse events across cancer types: Incidence, risk factors and survival

被引：0
|
作者：
Owen, D. H. [1 ]
Burkart, J. [1 ]
Patel, S. [1 ]
Wei, L. [2 ]
Tinoco, G. [1 ]
Liebner, D. [1 ]
He, K. [1 ]
Shields, P. G. [1 ]
Bertino, E. M. [1 ]
Presley, C. J. [1 ]
Johns, A. [1 ]
Folefac, E. [1 ]
Olencki, T. [1 ]
Carbone, D. P. [1 ]
Verschraegen, C. [1 ]
Otterson, G. A. [1 ]
Kendra, K. L. [1 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Div Med Oncol, James Canc Hosp, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, James Canc Hosp, Columbus, OH 43210 USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1772P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Organ-specific immune-related adverse events and survival in patients with cancer with immune checkpoint inhibitors
    Wang, Jun
    Han, Xinyue
    Chen, Yingcui
    Xie, Hong
    Zhang, Yuekai
    Cui, Yu
    Guan, Yaping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Oral and cutaneous immune-related adverse events in cancer patients: Prevalence and overall survival
    de Oliveira Filho, Osias Vieira
    Gibbons, Ivana Lameiras
    Medeiros, Yuri de Lima
    de Oliveira, Thiago Bueno
    Treister, Nathaniel Simon
    Alves, Fabio Abreu
    ORAL DISEASES, 2025, 31 (01) : 278 - 285
  • [23] Endocrine Immune-Related Adverse Events Are Independent Predictors of Survival in Patients with Lung Cancer
    Panagiotou, Emmanouil
    Ntouraki, Sofia
    Vathiotis, Ioannis A.
    Livanou, Maria Effrosyni
    Trimis, Athanasios
    Evangelou, Georgios
    Charpidou, Andriani
    Syrigos, Konstantinos
    Peppa, Melpomeni
    CANCERS, 2024, 16 (09)
  • [24] INCIDENCE AND RISK FACTORS FOR ADVERSE EVENTS AFTER ENDOSCOPIC ULTRASOUND
    Elfanagely, Yousef
    Tse, Chung Sang
    Monteiro, Joao Filipe G.
    Kogan, Lawrence
    Rich, Harlan
    Hyder, Sarah M.
    GASTROINTESTINAL ENDOSCOPY, 2020, 91 (06) : AB299 - AB300
  • [25] Adverse events in a Tunisian university hospital: incidence and risk factors
    Ghali, Hela
    Ben Cheikh, Asma
    Bhiri, Sana
    Ben Fredj, Sihem
    Layouni, Saoussen
    Khefacha, Salwa
    Dhidah, Lamine
    Ben Rejeb, Mohamed
    Latiri, Houyem Said
    SANTE PUBLIQUE, 2020, 32 (2-3): : 189 - 198
  • [26] INCIDENCE OF MUSCULOSKELETAL AND SKIN IMMUNE-RELATED ADVERSE EVENTS WITH IMMUNE CHECKPOINT INHIBITORS
    Kim, J. H.
    Ng, J.
    Sanmugarajah, J.
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 45 - 46
  • [27] Analyses of risk factors for adverse events with palbociclib and the association between adverse events occurrence and survival
    Ishikawa, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1602 - S1602
  • [28] Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
    Haddad, Tyler C.
    Zhao, Songzhu
    Li, Mingjia
    Patel, Sandip H.
    Johns, Andrew
    Grogan, Madison
    Lopez, Gabriella
    Miah, Abdul
    Wei, Lai
    Tinoco, Gabriel
    Riesenberg, Brian
    Li, Zihai
    Meara, Alexa
    Bertino, Erin M.
    Kendra, Kari
    Otterson, Gregory
    Presley, Carolyn J.
    Owen, Dwight H.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (05) : 1157 - 1165
  • [29] Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
    Tyler C. Haddad
    Songzhu Zhao
    Mingjia Li
    Sandip H. Patel
    Andrew Johns
    Madison Grogan
    Gabriella Lopez
    Abdul Miah
    Lai Wei
    Gabriel Tinoco
    Brian Riesenberg
    Zihai Li
    Alexa Meara
    Erin M. Bertino
    Kari Kendra
    Gregory Otterson
    Carolyn J. Presley
    Dwight H. Owen
    Cancer Immunology, Immunotherapy, 2022, 71 : 1157 - 1165
  • [30] RISK FACTORS FOR DEVELOPING RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS AFTER IMMUNOTHERAPY WITH IMMUNE CHECKPOINT INHIBITORS
    Liapi, M.
    Chatzidionysiou, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2053 - 2054
12345